0001127602-20-017757.txt : 20200522 0001127602-20-017757.hdr.sgml : 20200522 20200522161753 ACCESSION NUMBER: 0001127602-20-017757 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200520 FILED AS OF DATE: 20200522 DATE AS OF CHANGE: 20200522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANSTICE DAVID W CENTRAL INDEX KEY: 0001181171 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 20906117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-05-20 0001520262 Alkermes plc. ALKS 0001181171 ANSTICE DAVID W CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 IRELAND 1 Non Qualified Stock Option (Right to Buy) 16.85 2020-05-20 4 A 0 12823 0 A 2021-05-20 2030-05-20 Ordinary Shares 12823 12823 D Restricted Stock Unit Award 0 2020-05-20 4 A 0 6104 0 A 2021-05-20 Ordinary Shares 6104 6104 D This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic. This option becomes exercisable in full on 5/20/2021. Shares subject to the restricted stock unit award vest in full on 5/20/2021. /s/ Shantale Greenson, attorney-in-fact for David W. Anstice 2020-05-22